Component: (Network and Table)
Network
00100 - Statement - CONSOLIDATED BALANCE SHEETS
(http://www.theravance.com/role/StatementConsolidatedBalanceSheets)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001583107 (http://www.sec.gov/CIK)
CONSOLIDATED BALANCE SHEETSPeriod [Axis]
2016-12-31
2015-12-31
CONSOLIDATED BALANCE SHEETS
 
 
Assets
 
 
Current assets:
 
 
Cash and cash equivalents
344,709,000  
112,707,000  
Short-term marketable securities
156,387,000  
59,727,000  
Accounts receivable, net of allowances of $779 and $758 at December 31, 2016 and 2015, respectively
646,000  
1,922,000  
Receivables from collaborative arrangements
9,076,000  
35,232,000  
Prepaid taxes
3,060,000  
12,764,000  
Other prepaid and current assets
2,405,000  
5,115,000  
Inventories
12,220,000  
10,005,000  
Total current assets
528,503,000  
 
237,472,000  
 
Property and equipment, net
8,460,000  
9,873,000  
Long-term marketable securities
91,565,000  
42,860,000  
Other investments
8,000,000  
8,000,000  
Restricted cash
833,000  
833,000  
Other assets
1,893,000  
1,078,000  
Total assets
639,254,000  
 
300,116,000  
 
Liabilities and Shareholders' Equity
 
 
Current liabilities:
 
 
Accounts payable
1,733,000  
18,804,000  
Accrued personnel-related expenses
14,021,000  
10,866,000  
Accrued clinical and development expenses
25,064,000  
14,709,000  
Other accrued liabilities
8,298,000  
4,947,000  
Deferred revenue
152,000  
144,000  
Total current liabilities
49,268,000  
 
49,470,000  
 
Convertible senior notes, net
222,676,000  
0  
Deferred rent
3,966,000  
4,598,000  
Other long-term liabilities
13,113,000  
2,983,000  
Commitments and contingencies (Note 2, 8, 10)
xsi:nil  
xsi:nil  
Shareholders' equity
 
 
Preferred shares, $0.00001 par value: 230 shares authorized, no shares issued or outstanding at December 31, 2016 and 2015, respectively
xsi:nil  
xsi:nil  
Ordinary shares, $0.00001 par value: 200,000 shares authorized at December 31, 2016 and 2015: 52,833 and 37,981 shares issued and outstanding at December 31, 2016 and 2015, respectively
1,000  
xsi:nil  
Additional paid-in capital
862,708,000  
564,691,000  
Accumulated other comprehensive loss
(253,000) 
(70,000) 
Accumulated deficit
(512,225,000) 
(321,556,000) 
Total shareholders' equity
350,231,000  
 
243,065,000  
 
Total liabilities and shareholders' equity
639,254,000  
 
300,116,000